# ARS Pharmaceuticals, Inc.: Form 8-K, filed Dec 9, 2022

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: 8-K
- Filed: 2022-12-09
- Accepted by EDGAR: Dec 9, 2022, 17:02 ET
- Period: 2022-12-06
- Accession: 0001193125-22-301873
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119312522301873/d772949d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119312522301873/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119312522301873/d772949d8k.htm

Filed Dec 9, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-301873. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.
